Mesial prefrontal cortex degeneration in amyotrophic lateral sclerosis: A high-field proton MR spectroscopy study

U. Usman, C. Choi, R. Camicioli, P. Seres, M. Lynch, R. Sekhon, W. Johnston, Sanjay Kalra

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

BACKGROUND AND PURPOSE: Frontotemporal lobar degeneration is responsible for the cognitive abnormalities seen in patients with ALS. We sought to evaluate the in vivo neurochemical changes associated with this pathology indicative of neuronal loss and gliosis. MATERIALS AND METHODS: Twenty-four patients with ALS (2 with ALS-FTD) and 15 healthy controls were studied. High-field proton MR spectroscopy of the mesial prefrontal cortex was used to determine concentrations of NAA and mIns, markers of neuronal integrity and gliosis, respectively. Metabolite concentrations were correlated with cognitive tests (verbal fluency, ACE). RESULTS: NAA/mIns was decreased 17% (P = .002). Abnormalities were present to a lesser degree in the individual metabolites NAA (decreased 9%; P = .08) and mIns (increased 11%; P = .06) than the ratio of the 2 metabolites. These measures did not correlate significantly with verbal fluency or the ACE. CONCLUSIONS: Prefrontal lobe degeneration exists in patients with ALS as indicated by an abnormal mesial prefrontal cortex neurochemical profile. Further study is necessary to determine the potential utility of the NAA/mIns ratio as a biomarker for frontal lobe degeneration in ALS.

Original languageEnglish (US)
Pages (from-to)1677-1680
Number of pages4
JournalAmerican Journal of Neuroradiology
Volume32
Issue number9
DOIs
StatePublished - Oct 2011

Fingerprint

Amyotrophic Lateral Sclerosis
Prefrontal Cortex
Protons
Gliosis
Magnetic Resonance Spectroscopy
Frontotemporal Lobar Degeneration
Frontal Lobe
Biomarkers
Pathology

ASJC Scopus subject areas

  • Clinical Neurology
  • Radiology Nuclear Medicine and imaging

Cite this

Mesial prefrontal cortex degeneration in amyotrophic lateral sclerosis : A high-field proton MR spectroscopy study. / Usman, U.; Choi, C.; Camicioli, R.; Seres, P.; Lynch, M.; Sekhon, R.; Johnston, W.; Kalra, Sanjay.

In: American Journal of Neuroradiology, Vol. 32, No. 9, 10.2011, p. 1677-1680.

Research output: Contribution to journalArticle

Usman, U. ; Choi, C. ; Camicioli, R. ; Seres, P. ; Lynch, M. ; Sekhon, R. ; Johnston, W. ; Kalra, Sanjay. / Mesial prefrontal cortex degeneration in amyotrophic lateral sclerosis : A high-field proton MR spectroscopy study. In: American Journal of Neuroradiology. 2011 ; Vol. 32, No. 9. pp. 1677-1680.
@article{c828f8d92cbe4b1493d0cd86384ecf88,
title = "Mesial prefrontal cortex degeneration in amyotrophic lateral sclerosis: A high-field proton MR spectroscopy study",
abstract = "BACKGROUND AND PURPOSE: Frontotemporal lobar degeneration is responsible for the cognitive abnormalities seen in patients with ALS. We sought to evaluate the in vivo neurochemical changes associated with this pathology indicative of neuronal loss and gliosis. MATERIALS AND METHODS: Twenty-four patients with ALS (2 with ALS-FTD) and 15 healthy controls were studied. High-field proton MR spectroscopy of the mesial prefrontal cortex was used to determine concentrations of NAA and mIns, markers of neuronal integrity and gliosis, respectively. Metabolite concentrations were correlated with cognitive tests (verbal fluency, ACE). RESULTS: NAA/mIns was decreased 17{\%} (P = .002). Abnormalities were present to a lesser degree in the individual metabolites NAA (decreased 9{\%}; P = .08) and mIns (increased 11{\%}; P = .06) than the ratio of the 2 metabolites. These measures did not correlate significantly with verbal fluency or the ACE. CONCLUSIONS: Prefrontal lobe degeneration exists in patients with ALS as indicated by an abnormal mesial prefrontal cortex neurochemical profile. Further study is necessary to determine the potential utility of the NAA/mIns ratio as a biomarker for frontal lobe degeneration in ALS.",
author = "U. Usman and C. Choi and R. Camicioli and P. Seres and M. Lynch and R. Sekhon and W. Johnston and Sanjay Kalra",
year = "2011",
month = "10",
doi = "10.3174/ajnr.A2590",
language = "English (US)",
volume = "32",
pages = "1677--1680",
journal = "American Journal of Neuroradiology",
issn = "0195-6108",
publisher = "American Society of Neuroradiology",
number = "9",

}

TY - JOUR

T1 - Mesial prefrontal cortex degeneration in amyotrophic lateral sclerosis

T2 - A high-field proton MR spectroscopy study

AU - Usman, U.

AU - Choi, C.

AU - Camicioli, R.

AU - Seres, P.

AU - Lynch, M.

AU - Sekhon, R.

AU - Johnston, W.

AU - Kalra, Sanjay

PY - 2011/10

Y1 - 2011/10

N2 - BACKGROUND AND PURPOSE: Frontotemporal lobar degeneration is responsible for the cognitive abnormalities seen in patients with ALS. We sought to evaluate the in vivo neurochemical changes associated with this pathology indicative of neuronal loss and gliosis. MATERIALS AND METHODS: Twenty-four patients with ALS (2 with ALS-FTD) and 15 healthy controls were studied. High-field proton MR spectroscopy of the mesial prefrontal cortex was used to determine concentrations of NAA and mIns, markers of neuronal integrity and gliosis, respectively. Metabolite concentrations were correlated with cognitive tests (verbal fluency, ACE). RESULTS: NAA/mIns was decreased 17% (P = .002). Abnormalities were present to a lesser degree in the individual metabolites NAA (decreased 9%; P = .08) and mIns (increased 11%; P = .06) than the ratio of the 2 metabolites. These measures did not correlate significantly with verbal fluency or the ACE. CONCLUSIONS: Prefrontal lobe degeneration exists in patients with ALS as indicated by an abnormal mesial prefrontal cortex neurochemical profile. Further study is necessary to determine the potential utility of the NAA/mIns ratio as a biomarker for frontal lobe degeneration in ALS.

AB - BACKGROUND AND PURPOSE: Frontotemporal lobar degeneration is responsible for the cognitive abnormalities seen in patients with ALS. We sought to evaluate the in vivo neurochemical changes associated with this pathology indicative of neuronal loss and gliosis. MATERIALS AND METHODS: Twenty-four patients with ALS (2 with ALS-FTD) and 15 healthy controls were studied. High-field proton MR spectroscopy of the mesial prefrontal cortex was used to determine concentrations of NAA and mIns, markers of neuronal integrity and gliosis, respectively. Metabolite concentrations were correlated with cognitive tests (verbal fluency, ACE). RESULTS: NAA/mIns was decreased 17% (P = .002). Abnormalities were present to a lesser degree in the individual metabolites NAA (decreased 9%; P = .08) and mIns (increased 11%; P = .06) than the ratio of the 2 metabolites. These measures did not correlate significantly with verbal fluency or the ACE. CONCLUSIONS: Prefrontal lobe degeneration exists in patients with ALS as indicated by an abnormal mesial prefrontal cortex neurochemical profile. Further study is necessary to determine the potential utility of the NAA/mIns ratio as a biomarker for frontal lobe degeneration in ALS.

UR - http://www.scopus.com/inward/record.url?scp=80054032781&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80054032781&partnerID=8YFLogxK

U2 - 10.3174/ajnr.A2590

DO - 10.3174/ajnr.A2590

M3 - Article

C2 - 21778247

AN - SCOPUS:80054032781

VL - 32

SP - 1677

EP - 1680

JO - American Journal of Neuroradiology

JF - American Journal of Neuroradiology

SN - 0195-6108

IS - 9

ER -